Jean-Charles Soria to Melanoma
This is a "connection" page, showing publications Jean-Charles Soria has written about Melanoma.
Connection Strength
0.020
-
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy. J Clin Oncol. 2018 03 20; 36(9):850-858.
Score: 0.020